Zobrazeno 1 - 10
of 203
pro vyhledávání: '"Dusthackeer, A."'
Autor:
Vijayalakshmi Jawaharlal Nehru, Maria Jose Vandakunnel, Usharani Brammacharry, Venkateswari Ramachandra, Gunavathy Pradhabane, Balasundaram Revathi Mani, Azger Dusthackeer VN, Muthuraj Muthaiah
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Fluoroquinolone resistance is a major challenge in treating Multidrug-Resistant Tuberculosis globally. The GenoType MTBDRsl Ver 2.0, endorsed by the WHO, was used to characterize fluoroquinolone resistance. The fluoroquinolone resistance rat
Externí odkaz:
https://doaj.org/article/279d15a4fa174c7bb54b336ed699a248
Autor:
Chilamakuru, Naresh Babu, VN, Azger Dusthackeer, G, Varadaraj Bhat, Pallaprolu, Nikhil, Dande, Aishwarya, Nair, Dina, Pemmadi, Raghuveer Varma, Reddy Y, Padmanabha, Peraman, Ramalingam
Publikováno v:
In European Journal of Medicinal Chemistry 5 June 2024 272
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rajesh Mondal, Azger Dusthackeer V N, Palaniyandi Kannan, Amit Kumar Singh, Kannan Thiruvengadam, Radhakrishnan Manikkam, Shainaba A S, Mahizhaveni Balasubramanian, Padmasini Elango, Sam Ebenezer Rajadas, Dinesh Bharadwaj, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Hemanth Kumar A K, Manjula Singh, Shripad Patil, Jaleel U C A, Mukesh Doble, Balagurunathan R, Srikanth Prasad Tripathy, Vanaja Kumar
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0282454 (2023)
This study involves the in-vitro and in-vivo anti-TB potency and in-vivo safety of Transitmycin (TR) (PubChem CID:90659753)- identified to be a novel secondary metabolite derived from Streptomyces sp (R2). TR was tested in-vitro against drug resistan
Externí odkaz:
https://doaj.org/article/ee15a666eee34625950cbda74718b121
Autor:
Kaur, Parvinder, Potluri, Vijay, Ahuja, Vijay Kamal, Naveenkumar, C.N., Krishnamurthy, Ramya Vadageri, Gangadharaiah, Shruthi Thimmalapura, Shivarudraiah, Prasad, Eswaran, Sumesh, Nirmal, Christy Rosaline, Mahizhaveni, Balasubramanian, Dusthackeer, Azger, Mondal, Rajesh, Batt, Sarah M., Richardson, Emily J., Loman, Nicholas J., Besra, Gurdyal Singh, Shandil, Radha Krishan, Narayanan, Shridhar
Publikováno v:
In Tuberculosis July 2021 129
Publikováno v:
Journal of Respiration, Vol 1, Iss 2, Pp 141-164 (2021)
Pathogenic Mycobacterium tuberculosis complex organisms (MTBC) primarily cause pulmonary tuberculosis (PTB); however, MTBC are also capable of causing disease in extrapulmonary (EP) organs, which pose a significant threat to human health worldwide. E
Externí odkaz:
https://doaj.org/article/84bfcda3cee74f7582ae458a07f3664f
Autor:
Ramalingam Peraman, Sathish Kumar Sure, V. N. Azger Dusthackeer, Naresh Babu Chilamakuru, Padmanabha Reddy Yiragamreddy, Chiranjeevi Pokuri, Vinay Kumar Kutagulla, Santhivardhan Chinni
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 7, Iss 1, Pp 1-25 (2021)
Abstract Background Despite the various strategies undertaken in the clinical practice, the mortality rate due to antibiotic-resistant microbes has been markedly increasing worldwide. In addition to multidrug-resistant (MDR) microbes, the “ESKAPE
Externí odkaz:
https://doaj.org/article/c4c5d80db2a2449cb0d477fc3a6e0e11
Autor:
Mondal, Rajesh1 (AUTHOR), Dusthackeer V. N., Azger2 (AUTHOR) azgerdusthackeer.vn@icmr.gov.in, Kannan, Palaniyandi2 (AUTHOR), Singh, Amit Kumar3 (AUTHOR), Thiruvengadam, Kannan2 (AUTHOR), Manikkam, Radhakrishnan4 (AUTHOR), A. S., Shainaba2 (AUTHOR), Balasubramanian, Mahizhaveni2 (AUTHOR), Elango, Padmasini2 (AUTHOR), Ebenezer Rajadas, Sam2 (AUTHOR), Bharadwaj, Dinesh5 (AUTHOR), Arumugam, Gandarvakottai Senthilkumar6 (AUTHOR), Ganesan, Suresh6 (AUTHOR), Kumar A. K., Hemanth2 (AUTHOR), Singh, Manjula7 (AUTHOR), Patil, Shripad3 (AUTHOR), U. C. A., Jaleel8 (AUTHOR), Doble, Mukesh9 (AUTHOR), R., Balagurunathan10 (AUTHOR), Tripathy, Srikanth Prasad11 (AUTHOR)
Publikováno v:
PLoS ONE. 3/3/2023, Vol. 17 Issue 3, p1-17. 17p.
Publikováno v:
Indian Journal of Health Sciences and Biomedical Research KLEU, Vol 14, Iss 3, Pp 302-309 (2021)
Multidrug resistance tuberculosis (MDR-TB) associated with the development of resistance to fluoroquinolones (FQs) especially ofloxacin is a matter of concern, as they had been earlier recommended drugs for usage in the MDR-TB treatment regimens, and
Externí odkaz:
https://doaj.org/article/054c8b607854482ea34530ff5d554dda